Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.

Factor H is an abundant plasma glycoprotein that plays a critical role in the regulation of the complement system in plasma and in the protection of host cells and tissues from damage by complement activation. Several recent studies have described the association of genetic variations of the complement factor H gene (CFH) with atypical haemolytic uraemic syndrome (aHUS), age-related macular degeneration (AMD) and membranoproliferative glomerulonephritis (MPGN). This review summarizes our current knowledge of CFH genetics and examines the CFH genotype-phenotype correlations that are helping to understand the molecular basis underlying these renal and ocular pathologies.

[1]  M. Gubler,et al.  H deficiency in two brothers with atypical dense intramembranous deposit disease. , 1986, Kidney international.

[2]  B. Paul Morgan,et al.  Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome , 2007, Proceedings of the National Academy of Sciences.

[3]  Victoria A. Higman,et al.  His-384 Allotypic Variant of Factor H Associated with Age-related Macular Degeneration Has Different Heparin Binding Properties from the Non-disease-associated Form* , 2006, Journal of Biological Chemistry.

[4]  M. Kazatchkine,et al.  Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b. , 1979, Journal of immunology.

[5]  L. Almasy,et al.  Multipoint quantitative-trait linkage analysis in general pedigrees. , 1998, American journal of human genetics.

[6]  D. Pérez-Caballero,et al.  Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. , 2002, American journal of human genetics.

[7]  M. Jackson,et al.  De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome , 2006, Human mutation.

[8]  M. Dierich,et al.  Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts , 1991, European journal of immunology.

[9]  G. Remuzzi,et al.  Hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.

[10]  N. Orr,et al.  A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.

[11]  S. Meri,et al.  Analysis of the recognition mechanism of the alternative pathway of complement by monoclonal anti‐factor H antibodies: evidence for multiple interactions between H and surface bound C3b , 1996, FEBS letters.

[12]  G. Sutherland,et al.  Location and Structure of the Human FHR-5 Gene , 2002, Genetica.

[13]  D. Fearon.  Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[14]  C. Mold,et al.  C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. , 1984, Journal of immunology.

[15]  G. Remuzzi,et al.  The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. , 2001, Journal of the American Society of Nephrology : JASN.

[16]  P. Zipfel,et al.  Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. , 1995, Journal of immunology.

[17]  S. Ram,et al.  A Novel Sialic Acid Binding Site on Factor H Mediates Serum Resistance of Sialylated Neisseria gonorrhoeae , 1998, The Journal of experimental medicine.

[18]  J. Goodship,et al.  Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. , 2001, American journal of human genetics.

[19]  Don H. Anderson,et al.  Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein1 , 2007, The Journal of Immunology.

[20]  J. Goodship,et al.  Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome , 2007, PLoS genetics.

[21]  Yun Li,et al.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration , 2006, Nature Genetics.

[22]  W. Fridman,et al.  Anti-Factor H autoantibodies associated with atypical hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.

[23]  J. Esparza-Gordillo,et al.  Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree. , 2006, Molecular immunology.

[24]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Weiler,et al.  Control of the amplification convertase of complement by the plasma protein beta1H. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. López-Trascasa,et al.  O24Complement factor H haplotypes and copy number variations of the factor H-related genes in renal and ocular disorders , 2007 .

[27]  J. Atkinson,et al.  Hemolytic Uremic Syndrome: An Example of Insufficient Complement Regulation on Self‐Tissue , 2005, Annals of the New York Academy of Sciences.

[28]  John D Lambris,et al.  Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. , 2005, Journal of the American Society of Nephrology : JASN.

[29]  S. Meri,et al.  Localization of the heparin-binding site on complement factor H. , 1991, The Journal of biological chemistry.

[30]  S. Meri,et al.  FHL-1/reconectin and factor H: two human complement regulators which are encoded by the same gene are differently expressed and regulated. , 1999, Molecular immunology.

[31]  J. Lambris,et al.  Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. , 1985, The Biochemical journal.

[32]  R. Carmi,et al.  Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H , 1998, Pediatric Nephrology.

[33]  S. Rodríguez de Córdoba,et al.  Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H. , 2004, Molecular immunology.

[34]  W. Fridman,et al.  Development of anti-factor H auto-antibodies genetically predisposed in atypical HUS , 2007 .

[35]  J. Goodship,et al.  Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome. , 2005, Journal of the American Society of Nephrology : JASN.

[36]  D. Pérez-Caballero,et al.  Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. , 2001, American journal of human genetics.

[37]  W. Fridman,et al.  Protective or aggressive: Paradoxical role of C3 in atypical hemolytic uremic syndrome , 2007 .

[38]  D. Heine-Suñer,et al.  An integrated map of the human regulator of complement activation (RCA) gene cluster on 1q32. , 1999, Molecular immunology.

[39]  D. Uhrín,et al.  Structural basis for complement factor H–linked age-related macular degeneration , 2007, The Journal of experimental medicine.

[40]  P. Zipfel,et al.  Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). , 2006, Kidney International.

[41]  P. Zipfel,et al.  Complement factor H and related proteins: an expanding family of complement-regulatory proteins? , 1994, Immunology today.

[42]  M. Walport,et al.  Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains , 2007, The Journal of experimental medicine.

[43]  J. Goodship,et al.  Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency and affect recognition functions , 2007 .

[44]  R. Thompson,et al.  Hypocomplementaemia due to a genetic deficiency of beta 1H globulin. , 1981, Clinical and experimental immunology.

[45]  M. Jackson,et al.  Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene , 2006, PLoS medicine.

[46]  J. Hollyfield,et al.  Effects on factor H function of polymorphisms linked to age-related macular degeneration , 2007 .

[47]  P. Zipfel,et al.  FHL-1/reconectin: a human complement and immune regulator with cell-adhesive function. , 1999, Immunology today.

[48]  S. Meri,et al.  The factor H protein family. , 1999, Immunopharmacology.

[49]  Robert F Mullins,et al.  A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.

[50]  H. Colten,et al.  Complement biosynthesis by the human hepatoma-derived cell line HepG2. , 1982, The Journal of clinical investigation.

[51]  H. Colten,et al.  Human Factor H Deficiency , 1997, The Journal of Biological Chemistry.

[52]  U. Schlötzer-Schrehardt,et al.  Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. , 2007, Molecular immunology.

[53]  W. Schürch,et al.  Familial hemolytic-uremic syndrome and homozygous factor H deficiency. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[54]  C. López-Larrea,et al.  A familial deficiency of complement factor H , 1987 .

[55]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[56]  H. Deng,et al.  The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts , 2005, Journal of Medical Genetics.

[57]  L. Almasy,et al.  Genetic and environmental factors influencing the human factor H plasma levels , 2004, Immunogenetics.

[58]  M. Walport,et al.  Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H , 2002, Nature Genetics.

[59]  M. Pepys,et al.  Binding of factor H to C-reactive protein occurs only when the latter has undergone non-physiologic denaturation , 2007 .

[60]  T. Schulz,et al.  Human complement factor H: expression of an additional truncated gene product of 43 kDa in human liver , 1987, European journal of immunology.

[61]  R. Schreiber,et al.  Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[62]  A. Buil,et al.  Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. , 2005, Human molecular genetics.

[63]  Johanna M Seddon,et al.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.

[64]  P. Zipfel,et al.  Complement and diseases: defective alternative pathway control results in kidney and eye diseases. , 2006, Molecular immunology.

[65]  M. Lokki,et al.  Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes , 2004, Immunogenetics.

[66]  J. Volanakis,et al.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. , 1974, Journal of immunology.

[67]  D. Power,et al.  Human Factor H-related Protein 5 (FHR-5) , 2001, The Journal of Biological Chemistry.

[68]  D. Heine-Suñer,et al.  A radiation hybrid map of complement factor H and factor H-related genes , 1999, Immunogenetics.

[69]  C. Keilhauer,et al.  An update on the genetics of age-related macular degeneration , 2007, Molecular vision.

[70]  J. Goodship,et al.  Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  D. Lublin,et al.  Identification of complement regulatory domains in human factor H. , 1995, Journal of immunology.

[72]  Don H. Anderson,et al.  Extended haplotypes in the complement factor H (CFH) and CFH‐related (CFHR) family of genes protect against age‐related macular degeneration: Characterization, ethnic distribution and evolutionary implications , 2006, Annals of medicine.

[73]  P. Sánchez-Corral,et al.  O35Factor H allele-specific quantification in Tyr402His heterozygotes reveals the existence of low-expression alleles associated with atypical haemolytic uraemic syndrome , 2007 .

[74]  S. Muller,et al.  Heteroclitic properties of mixed α-and aza-β3-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome , 2007 .

[75]  W. Fridman,et al.  Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome , 2004, Journal of Medical Genetics.

[76]  G. Deschênes,et al.  Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. , 2004, Journal of the American Society of Nephrology : JASN.

[77]  D. Lenk,et al.  Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries , 2003, Journal of medical genetics.

[78]  A. Blom,et al.  The Factor H Variant Associated with Age-related Macular Degeneration (His-384) and the Non-disease-associated Form Bind Differentially to C-reactive Protein, Fibromodulin, DNA, and Necrotic Cells* , 2007, Journal of Biological Chemistry.

[79]  P. Zipfel,et al.  Identification of the second heparin-binding domain in human complement factor H. , 1998, Journal of immunology.

[80]  M. Oppermann,et al.  Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. , 2007, Blood.

[81]  S. Ranganathan,et al.  A common site within factor H SCR 7 responsible for binding heparin, C‐reactive protein and streptococcal M protein , 2003 .

[82]  M. Kazatchkine,et al.  Human complement factor H deficiency associated with hemolytic uremic syndrome. , 1998, Journal of the American Society of Nephrology : JASN.

[83]  S. Ranganathan,et al.  Complement factor H: sequence analysis of 221 kb of human genomic DNA containing the entire fH, fHR-1 and fHR-3 genes. , 2000, Molecular immunology.

[84]  S. Meri,et al.  Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H. , 1999, Journal of immunology.

[85]  K. Whaley,et al.  Modulation of the alternative complement pathways by beta 1 H globulin , 1976, The Journal of experimental medicine.

[86]  D. Uhrín,et al.  Structure Shows That a Glycosaminoglycan and Protein Recognition Site in Factor H Is Perturbed by Age-related Macular Degeneration-linked Single Nucleotide Polymorphism* , 2007, Journal of Biological Chemistry.

[87]  M. Dierich,et al.  Human complement factor H: An additional gene product of 43kDa isolated from human plasma shows cofactor activity for the cleavage of the third component of complement , 1989, European journal of immunology.

[88]  R. Schreiber,et al.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution , 1977, The Journal of experimental medicine.

[89]  G. Hageman,et al.  Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.

[90]  J. Goodship,et al.  Genetic studies into inherited and sporadic hemolytic uremic syndrome. , 1998, Kidney international.

[91]  D. Lublin,et al.  Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. , 1996, Journal of immunology.

[92]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[93]  G. Remuzzi,et al.  Familial haemolytic uraemic syndrome and an MCP mutation , 2003, The Lancet.

[94]  J. H. Jansen,et al.  Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. , 1995, The Journal of clinical investigation.

[95]  S. Rodríguez de Córdoba,et al.  Human genes for three complement components that regulate the activation of C3 are tightly linked , 1985, The Journal of experimental medicine.

[96]  R. Schreiber,et al.  C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. , 1983, Journal of immunology.

[97]  J. Forrester,et al.  Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. , 2007, Experimental eye research.

[98]  G. Rivas,et al.  P112Analytical ultracentrifugation analysis of the human complement factor H variants 402His and 402Tyr , 2007 .

[99]  S. Fisher,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk , 2005 .

[100]  P. Zipfel,et al.  The Human Factor H-related Protein 4 (FHR-4) , 1997, The Journal of Biological Chemistry.

[101]  Robert B Sim,et al.  The complete amino acid sequence of human complement factor H. , 1988, The Biochemical journal.

[102]  J L McRae,et al.  Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease) , 2005, Journal of Medical Genetics.

[103]  G. Remuzzi,et al.  Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. , 2003, Human molecular genetics.

[104]  S. Rodríguez de Córdoba,et al.  The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.

[105]  Stefan Heinen,et al.  Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. , 2003, The Journal of clinical investigation.